Jenburkt Pharmaceuticals, a company in the Pharmaceuticals industry, reported revenue of ₹48 crore and net profit of ₹10 crore for the September 2026 quarter.
Jenburkt Pharmaceuticals (NSE: JENBURPH) closed at ₹893.20 on 20 Nov 2026. Its market capitalisation is ₹394 crore and it trades at 11.0 times earnings.
Incorporated in 1985, Jenburkt Pharmaceuticals Ltd manufactures and markets branded Pharmaceuticals and health care products
Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.